ArticleCureus2026
Prevalence and Pattern of Hemoglobinopathies Among Women of Reproductive Age Attending a Tertiary Care Center in Central Uttar Pradesh: A Prospective Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Hemoglobinopathies are an important public health concern in India, with considerable variation across regions. Screening women of reproductive age can help identify carriers early and provide opportunities for reproductive counselling. This study assessed the prevalence and pattern of hemoglobinopathies among women attending a tertiary care center in Central Uttar Pradesh. Methods A prospective observational study was conducted among women aged 15-49 years attending antenatal and outpatient services at a tertiary care hospital in Kanpur from 3 February 2025 to 2 February 2026. A total of 5,285 participants were screened. Those with abnormal or suggestive findings underwent further evaluation using complete blood count parameters and high-performance liquid chromatography. Diagnostic categories and hematological parameters were compared using appropriate statistical tests. Results Hemoglobinopathy was identified in 206 of 5,285 participants, giving an overall prevalence of 3.89%. Among the 207 participants with sufficient diagnostic information, beta-thalassemia trait was the most common finding (185; 89.4%), followed by hemoglobin E trait (20; 9.7%) and delta-beta-thalassemia trait (1; 0.5%). The prevalence of beta-thalassemia trait among the screened population was 3.5%. Significant differences were observed in red cell distribution width, hemoglobin, hemoglobin A, hemoglobin A2, and fetal hemoglobin (all p<0.001), while mean corpuscular volume and mean corpuscular hemoglobin did not differ significantly. Anemia severity also differed significantly (p=0.017). Conclusion Hemoglobinopathies were identified in a notable proportion of women screened, with beta-thalassemia trait being the predominant finding. These findings highlight the importance of carrier screening among women of reproductive age. The hospital-based design should be considered when interpreting the prevalence estimates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.